Stocks Health care HSCS
NASDAQ · Health careHeartSciences Inc. (HSCS)
HeartSciences Inc. brought in $4.5K of revenue over the twelve months to July 31, 2026. It posted a net loss of $10.3M. In fiscal 2026 capital spending exceeded operating cash flow by $7.4M. At July 31, 2026 it held $29.9K in cash. Its latest periodic report to the SEC is the quarterly report (10-Q) filed on September 14, 2026.
What HeartSciences Inc. does
HeartSciences Inc. is registered with the SEC under industry code SIC 6199 (Finance Services). Its shares trade on NASDAQ under the ticker HSCS.
Revenue and profit by year
Key figures
| Fiscal year | Revenue | Net income | Diluted EPS | Free cash flow |
|---|---|---|---|---|
| 2026 | $4.3K | -$9.1M | -$3.48 | -$7.4M |
| 2025 | $4.4K | -$8.8M | -$9.34 | -$7.4M |
| 2024 | $18.6K | -$6.6M | -$18.74 | -$6.1M |
| 2023 | $5.2K | -$6.4M | -$80.00 | -$5.8M |
| 2023 | $14.4K | -$4.8M | -$145.00 | -$3.6M |
Full financial statements: income, balance sheet and cash flow
Where HSCS ranks in Health care
Latest SEC filings
What HeartSciences Inc. has filed recently, newest first. Each links to the original document on SEC EDGAR.
- September 25, 2026
- September 24, 2026Additional proxy material DEFA14A
- September 21, 2026Additional proxy material DEFA14A
- September 18, 2026Additional proxy material DEFA14A
- September 18, 2026Form PRER14A filing PRER14A
- September 17, 2026Additional proxy material DEFA14A
- September 17, 2026Additional proxy material DEFA14A
- September 17, 2026
- September 16, 2026Additional proxy material DEFA14A
- September 15, 2026Additional proxy material DEFA14A
Insider trades
What the people running HeartSciences Inc. did with its shares, from the Form 4 filings they must send the SEC within two business days.
No insider trades were reported in the last 90 days.
| Date | Insider | What | Shares | Value |
|---|---|---|---|---|
| June 22, 2026 | Simpson AndrewSee Remarks, Director | Received as pay | 425,000 | - |
Who owns HSCS
Three views from three kinds of SEC filings, each with its own date. They overlap and are not added up.
5% holders
Largest institutional holders
Insiders
1 insiders reported holding 499,382 shares in total, about $2.4M at the last price.
| Holder | Shares |
|---|---|
| Simpson AndrewSee Remarks, Director | 499,382 |
Questions about HSCS
What does HeartSciences Inc. do?
HeartSciences Inc. is registered with the SEC under industry code SIC 6199 (Finance Services). Its shares trade on NASDAQ under the ticker HSCS.
Is HeartSciences Inc. profitable?
No. Over the twelve months to July 31, 2026 it reported a net loss of $10.3M on revenue of $4.5K.
How much revenue does HeartSciences Inc. make?
Over the twelve months to July 31, 2026 HeartSciences Inc. reported revenue of $4.5K.
When did HeartSciences Inc. last report?
Its most recent periodic report is the quarterly report (10-Q) filed on September 14, 2026. It covers the period to July 31, 2026. Its newest filing of any kind is the shelf registration to sell securities from September 25, 2026.
Similar companies
Compare HSCS with
Follow HSCS
Get an email when HeartSciences Inc. files with the SEC: results, executive changes, material agreements and annual reports.
Follow HSCS: get an email when it filesWhere the numbers come from
Financial figures are the values HeartSciences Inc. tagged in its own SEC filings (XBRL), taken from the latest filing for each period, so restatements replace older figures. Revenue, profit and cash flow are for full fiscal years unless marked as the last twelve months, which is the sum of the four most recent quarters. Where a company reports only the full year, the fourth quarter is the year minus the first three.
Prices are delayed end-of-day market data in the listing currency, and market cap moves with the price. P/E is shown only when earnings per share are positive. Nothing here is investment advice.